ScinoPharm Taiwan Ltd
TWSE:1789
ScinoPharm Taiwan Ltd
TWSE:1789
Price:
22.7
TWD
-1.09%
Market Closed
Market Cap:
17.9B
TWD
Income Statement
Earnings Waterfall
ScinoPharm Taiwan Ltd
ScinoPharm Taiwan Ltd
|
Revenue
|
3.5B
TWD
|
|
Cost of Revenue
|
-2.1B
TWD
|
|
Gross Profit
|
1.4B
TWD
|
|
Operating Expenses
|
-934.3m
TWD
|
|
Operating Income
|
446.4m
TWD
|
|
Other Expenses
|
-47m
TWD
|
|
Net Income
|
399.4m
TWD
|
Income Statement
ScinoPharm Taiwan Ltd
ScinoPharm Taiwan Ltd
Currency: TWD
Millions
TTM
| Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
4 572
N/A
|
4 098
-10%
|
3 980
-3%
|
3 795
-5%
|
3 775
-1%
|
3 955
+5%
|
3 998
+1%
|
4 050
+1%
|
4 059
+0%
|
4 031
-1%
|
3 929
-3%
|
3 767
-4%
|
3 624
-4%
|
3 516
-3%
|
3 458
-2%
|
3 591
+4%
|
3 560
-1%
|
3 524
-1%
|
3 435
-3%
|
3 067
-11%
|
2 933
-4%
|
2 893
-1%
|
2 663
-8%
|
2 954
+11%
|
3 028
+3%
|
3 083
+2%
|
3 182
+3%
|
3 021
-5%
|
2 917
-3%
|
2 762
-5%
|
2 859
+4%
|
2 917
+2%
|
2 968
+2%
|
3 264
+10%
|
3 175
-3%
|
3 124
-2%
|
3 079
-1%
|
3 186
+3%
|
3 421
+7%
|
3 428
+0%
|
3 493
+2%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(2 632)
|
(2 497)
|
(2 468)
|
(2 418)
|
(2 319)
|
(2 279)
|
(2 234)
|
(2 186)
|
(2 182)
|
(2 225)
|
(2 084)
|
(2 061)
|
(1 977)
|
(1 966)
|
(2 044)
|
(2 081)
|
(2 116)
|
(1 982)
|
(1 897)
|
(1 676)
|
(1 591)
|
(1 716)
|
(1 572)
|
(1 699)
|
(1 691)
|
(1 765)
|
(1 744)
|
(1 684)
|
(1 712)
|
(1 482)
|
(1 646)
|
(1 695)
|
(1 748)
|
(2 013)
|
(1 977)
|
(1 990)
|
(1 954)
|
(1 970)
|
(2 095)
|
(2 095)
|
(2 112)
|
|
| Gross Profit |
1 940
N/A
|
1 601
-17%
|
1 512
-6%
|
1 377
-9%
|
1 457
+6%
|
1 677
+15%
|
1 764
+5%
|
1 863
+6%
|
1 876
+1%
|
1 806
-4%
|
1 845
+2%
|
1 706
-8%
|
1 647
-3%
|
1 550
-6%
|
1 414
-9%
|
1 509
+7%
|
1 444
-4%
|
1 543
+7%
|
1 538
0%
|
1 391
-10%
|
1 342
-4%
|
1 176
-12%
|
1 091
-7%
|
1 255
+15%
|
1 338
+7%
|
1 317
-2%
|
1 438
+9%
|
1 337
-7%
|
1 205
-10%
|
1 280
+6%
|
1 213
-5%
|
1 222
+1%
|
1 219
0%
|
1 251
+3%
|
1 197
-4%
|
1 134
-5%
|
1 125
-1%
|
1 216
+8%
|
1 325
+9%
|
1 333
+1%
|
1 381
+4%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(1 149)
|
(1 041)
|
(994)
|
(945)
|
(920)
|
(927)
|
(959)
|
(956)
|
(950)
|
(938)
|
(951)
|
(955)
|
(978)
|
(991)
|
(955)
|
(977)
|
(940)
|
(984)
|
(983)
|
(935)
|
(978)
|
(910)
|
(897)
|
(915)
|
(926)
|
(942)
|
(996)
|
(988)
|
(957)
|
(992)
|
(945)
|
(930)
|
(878)
|
(845)
|
(831)
|
(856)
|
(877)
|
(901)
|
(908)
|
(891)
|
(934)
|
|
| Selling, General & Administrative |
(694)
|
(625)
|
(595)
|
(591)
|
(589)
|
(603)
|
(644)
|
(647)
|
(650)
|
(658)
|
(675)
|
(672)
|
(684)
|
(677)
|
(650)
|
(660)
|
(655)
|
(671)
|
(675)
|
(672)
|
(681)
|
(671)
|
(662)
|
(682)
|
(684)
|
(696)
|
(708)
|
(692)
|
(681)
|
(686)
|
(681)
|
(658)
|
(613)
|
(574)
|
(533)
|
(523)
|
(522)
|
(544)
|
(551)
|
(558)
|
(547)
|
|
| Research & Development |
(455)
|
(416)
|
(399)
|
(355)
|
(331)
|
(324)
|
(316)
|
(309)
|
(305)
|
(280)
|
(276)
|
(283)
|
(294)
|
(314)
|
(306)
|
(317)
|
(285)
|
(313)
|
(308)
|
(263)
|
(296)
|
(238)
|
(235)
|
(232)
|
(243)
|
(246)
|
(231)
|
(243)
|
(219)
|
(306)
|
(265)
|
(274)
|
(264)
|
(271)
|
(298)
|
(333)
|
(355)
|
(358)
|
(356)
|
(334)
|
(387)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(57)
|
(53)
|
(57)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
791
N/A
|
559
-29%
|
518
-7%
|
432
-17%
|
537
+24%
|
750
+40%
|
804
+7%
|
907
+13%
|
926
+2%
|
868
-6%
|
894
+3%
|
751
-16%
|
670
-11%
|
559
-17%
|
459
-18%
|
533
+16%
|
504
-5%
|
558
+11%
|
554
-1%
|
456
-18%
|
364
-20%
|
267
-27%
|
194
-27%
|
340
+75%
|
411
+21%
|
376
-9%
|
441
+17%
|
349
-21%
|
248
-29%
|
289
+16%
|
268
-7%
|
292
+9%
|
342
+17%
|
405
+19%
|
367
-10%
|
279
-24%
|
248
-11%
|
314
+27%
|
417
+33%
|
442
+6%
|
446
+1%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
15
|
39
|
31
|
137
|
111
|
52
|
60
|
(72)
|
(78)
|
(47)
|
(78)
|
(58)
|
(55)
|
(86)
|
(86)
|
(83)
|
(72)
|
(57)
|
(40)
|
(38)
|
(20)
|
(15)
|
3
|
(1)
|
(16)
|
(17)
|
(22)
|
(17)
|
(2)
|
6
|
12
|
16
|
29
|
18
|
16
|
26
|
20
|
27
|
47
|
53
|
46
|
|
| Non-Reccuring Items |
2
|
0
|
0
|
0
|
1
|
4
|
4
|
5
|
0
|
(1)
|
(1)
|
(2)
|
(2)
|
4
|
4
|
4
|
4
|
2
|
2
|
2
|
2
|
(1)
|
(1)
|
(1)
|
(1)
|
4
|
4
|
0
|
4
|
1
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
1
|
(4)
|
(4)
|
(5)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(3)
|
(0)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(4)
|
|
| Total Other Income |
(8)
|
8
|
7
|
7
|
(1)
|
(2)
|
(8)
|
(12)
|
(18)
|
(9)
|
(3)
|
0
|
(2)
|
(1)
|
(3)
|
(2)
|
(1)
|
(13)
|
(12)
|
(10)
|
(5)
|
14
|
14
|
11
|
9
|
(2)
|
(1)
|
0
|
(2)
|
7
|
7
|
8
|
10
|
14
|
12
|
15
|
13
|
7
|
7
|
1
|
2
|
|
| Pre-Tax Income |
801
N/A
|
602
-25%
|
552
-8%
|
571
+4%
|
645
+13%
|
803
+24%
|
860
+7%
|
828
-4%
|
830
+0%
|
811
-2%
|
812
+0%
|
691
-15%
|
611
-12%
|
475
-22%
|
373
-21%
|
452
+21%
|
435
-4%
|
491
+13%
|
504
+3%
|
409
-19%
|
340
-17%
|
265
-22%
|
210
-21%
|
350
+67%
|
403
+15%
|
359
-11%
|
422
+18%
|
331
-22%
|
247
-25%
|
302
+22%
|
286
-5%
|
315
+10%
|
381
+21%
|
438
+15%
|
394
-10%
|
319
-19%
|
282
-12%
|
349
+24%
|
471
+35%
|
495
+5%
|
490
-1%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(57)
|
(118)
|
(120)
|
(200)
|
(201)
|
(168)
|
(166)
|
(91)
|
(123)
|
(152)
|
(155)
|
(124)
|
(103)
|
(53)
|
14
|
(18)
|
(25)
|
(48)
|
(118)
|
(97)
|
(79)
|
(48)
|
(36)
|
(71)
|
(81)
|
(76)
|
(85)
|
(66)
|
(49)
|
(59)
|
(56)
|
(62)
|
(76)
|
(85)
|
(76)
|
(58)
|
(50)
|
(62)
|
(86)
|
(92)
|
(91)
|
|
| Income from Continuing Operations |
744
|
484
|
432
|
371
|
445
|
635
|
694
|
736
|
707
|
659
|
657
|
567
|
508
|
422
|
388
|
434
|
410
|
443
|
386
|
312
|
262
|
217
|
174
|
279
|
323
|
282
|
337
|
266
|
198
|
243
|
230
|
254
|
305
|
353
|
318
|
261
|
231
|
287
|
385
|
403
|
399
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
744
N/A
|
484
-35%
|
432
-11%
|
371
-14%
|
445
+20%
|
635
+43%
|
694
+9%
|
736
+6%
|
707
-4%
|
659
-7%
|
657
0%
|
567
-14%
|
508
-10%
|
422
-17%
|
388
-8%
|
434
+12%
|
410
-6%
|
443
+8%
|
386
-13%
|
312
-19%
|
262
-16%
|
217
-17%
|
174
-20%
|
279
+60%
|
323
+16%
|
282
-13%
|
337
+19%
|
266
-21%
|
198
-25%
|
243
+23%
|
230
-5%
|
254
+10%
|
305
+20%
|
353
+16%
|
318
-10%
|
261
-18%
|
231
-11%
|
287
+24%
|
385
+34%
|
403
+5%
|
399
-1%
|
|
| EPS (Diluted) |
0.93
N/A
|
0.61
-34%
|
0.54
-11%
|
0.47
-13%
|
0.57
+21%
|
0.8
+40%
|
0.89
+11%
|
0.94
+6%
|
0.9
-4%
|
0.83
-8%
|
0.82
-1%
|
0.71
-13%
|
0.64
-10%
|
0.53
-17%
|
0.5
-6%
|
0.56
+12%
|
0.52
-7%
|
0.56
+8%
|
0.49
-13%
|
0.39
-20%
|
0.33
-15%
|
0.27
-18%
|
0.22
-19%
|
0.35
+59%
|
0.41
+17%
|
0.36
-12%
|
0.43
+19%
|
0.34
-21%
|
0.25
-26%
|
0.31
+24%
|
0.29
-6%
|
0.32
+10%
|
0.39
+22%
|
0.45
+15%
|
0.4
-11%
|
0.33
-18%
|
0.29
-12%
|
0.36
+24%
|
0.49
+36%
|
0.51
+4%
|
0.5
-2%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
